N
1.50
-0.03 (-1.96%)
| Penutupan Terdahulu | 1.53 |
| Buka | 1.54 |
| Jumlah Dagangan | 81,780 |
| Purata Dagangan (3B) | 65,048 |
| Modal Pasaran | 12,214,701 |
| Harga / Pendapatan (P/E Ke hadapan) | 15.20 |
| Harga / Jualan (P/S) | 0.840 |
| Harga / Buku (P/B) | 2.01 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 11 Nov 2025 |
| Margin Keuntungan | -30.70% |
| Margin Operasi (TTM) | -27.69% |
| EPS Cair (TTM) | -0.450 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 121.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 49.25% |
| Nisbah Semasa (MRQ) | 1.88 |
| Aliran Tunai Operasi (OCF TTM) | -3.17 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.58 M |
| Pulangan Atas Aset (ROA TTM) | -20.77% |
| Pulangan Atas Ekuiti (ROE TTM) | -60.08% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | NexGel, Inc | Bercampur | Bercampur |
AISkor Stockmoo
1.0
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | -2.5 |
| Purata | 1.00 |
|
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 16.15% |
| % Dimiliki oleh Institusi | 8.43% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Simon Quick Advisors, Llc | 30 Sep 2025 | 35,715 |
| Flaharty Asset Management, Llc | 30 Sep 2025 | 24,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 16 Dec 2025 | Pengumuman | NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor |
| 11 Dec 2025 | Pengumuman | NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |